• Skip to main content
CQDM
  • About
    • Who We Are ?
    • Team
    • Governance
    • EDI
    • Contact us
  • Achievement
    • Success Story
    • Structuring Initiatives
    • Funded Projects
  • Funding R&D
    • Program Overview
    • SynergiQC
    • Quantum Leap
    • Partenar-IA
    • Funding for Company-driven RNA Innovation | AReNA
    • Call for Research Projects on the Brain
  • Members and Partners
    • Become a Member
    • Our members
    • Our Partners
  • News and Events
    • Our News
    • News from the industry
    • Our Events
  • Careers
    • Working at CQDM
    • Available Positions
  • fr Changer la langue pour du français.
  • en Current language: English.
  • About
    • Who We Are ?
    • Team
    • Governance
    • EDI
    • Contact us
  • Achievement
    • Success Story
    • Structuring Initiatives
    • Funded Projects
  • Funding R&D
    • Program Overview
    • SynergiQC
    • Quantum Leap
    • Partenar-IA
    • Funding for Company-driven RNA Innovation | AReNA
    • Call for Research Projects on the Brain
  • Members and Partners
    • Become a Member
    • Our members
    • Our Partners
  • News and Events
    • Our News
    • News from the industry
    • Our Events
  • Careers
    • Working at CQDM
    • Available Positions

Category: Our News

  1. CQDM
  2. Our News

CQDM acknowledges the success of the Forum Québécois des Sciences de la Vie which was organized by the government of Quebec

The first CQDM funded project is a remarkable success – Thanks to CQDM funding, Medicago announces an important investment in Québec

CQDM is proud to announce an investment of $1.5 M in two collaborative projects from the Québec/Ontario corridor

CQDM will receive a grant from the BL-NCE to research better ways of developing and testing drugs that treat central nervous system diseases

Communicating Life Sciences to the Public: Winners of “Tweete tes neurones!” challenge pitch in

The CQDM and Univalor have announced a collaboration agreement

The CQDM joins Genome Québec and the Ontario Genomics Institute for a partnering event in Toronto

CQDM Welcomes Eli Lilly Canada, A Leading Innovative Pharmaceutical Company, to Support the Explore Program

Défi Tweete tes neurones! – Optimum Vice President and general manager, Isabelle Perras, agrees to act as president of the jury

CQDM welcomes two additional Pharma members, Boehringer Ingelheim and GlaxoSmithKline Inc.

Posts navigation

Older posts
Newer posts
CQDM
Contact us
LinkedIn Twitter

© 2026 CQDM. All rights reserved.

  • Terms of Use
  • Privacy Policy
  • Site Map
  • Gérer mes Cookies
Manage your preferences
To provide the best experiences, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Failure to consent or withdrawal of consent may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of transmitting a communication over an electronic communications network.
Preferences
Storage or technical access is necessary for the legitimate purpose of storing preferences not requested by the subscriber or user.
Statistics
Storage or technical access used exclusively for statistical purposes. Technical storage or access which is used exclusively for anonymous statistical purposes. In the absence of a subpoena, voluntary compliance by your internet service provider or additional records from a third party, information stored or retrieved for this sole purpose cannot generally be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles in order to send advertisements, or to track the user on a website or on several websites with similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
See your preferences
  • {title}
  • {title}
  • {title}